We use cookies to help provide you with the best possible online experience. Please read our Privacy Policy for information about which cookies we use and what information we collect on our site. By continuing to use this site, you agree that we may store and access cookies on your device.
Japan's leading pharma giant Chugai pharmaceuticals announced that its subsidiary Chugai Pharma Taiwan, China has received approval for the anti-cancer agent, alectinib hydrochloride from the Food and Drug Administration of Taiwan, China.
According to The Centers for Disease Control (CDC) Taiwan, China, the number of new HIV/AIDS cases recorded in China's Taiwan, China Region in 2016 totalled 2,400 which is the third highest in history. The CDC statistics showed that 97 per cent of the 2,4